SCHEMBL5607040

SCHEMBL5607040

O=c1c2ccccc2nc(Cl)n1-c1cc(F)cc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 2/20 0.48
IDO1 P14902 2/20 0.48
TDO2 P48775 2/20 0.48
IDO2 Q6ZQW0 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
MITF O75030 1/20 0.48
HSP90AA1 P07900 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
GLA P06280 1/20 0.48
PDE7A Q13946 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
PDE7B Q9NP56 1/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31419814 0.87 ALDH1A1 (0.56) APAF1IDO1TDO2IDO2MEN1
SCHEMBL10552036 0.84 NPC1 (0.58) MEN1KMT2ANPC1HSP90AA1RAB9A
SCHEMBL30103255 0.84 NPC1 (0.58) MEN1KMT2ANPC1HSP90AA1RAB9A
SCHEMBL9953129 0.82 POLB (0.41) IDO1TDO2IDO2POLBPIK3CD
SCHEMBL15815616 0.80 PIK3CD (0.57) APAF1IDO1TDO2IDO2MEN1
SCHEMBL15815615 0.80 PIK3CD (0.57) APAF1IDO1TDO2IDO2MEN1
SCHEMBL23045340 0.79 TDO2 (0.54) IDO1TDO2IDO2POLB
SCHEMBL29623384 0.79 TDO2 (0.54) IDO1TDO2IDO2POLB
SCHEMBL28367595 0.78 SMN1; SMN2 (0.66) MEN1KMT2ARAB9ASMN1; SMN2LMNA
SCHEMBL15819241 0.77 PDE10A (0.53) MEN1KMT2ANPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1750715-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2007-02-14 EP disclosed
WO-2005120511-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2005-12-22 WO disclosed